Track analytical method transfer through evidence and exceptions

Sending a method is an early milestone

The sending laboratory uploads an approved procedure and marks its transfer task complete. The receiving laboratory discovers that its instrument configuration differs and the reporting template expects another unit. Both teams have worked, but readiness remains unresolved.

Pharma analytical method transfer should establish whether the receiving laboratory can perform the intended analytical work under the approved approach. Document delivery supports that decision; it does not make it. A useful workflow connects preparation, execution, exceptions and acceptance so neither laboratory has to reconstruct the story from email.

ICH Q2(R2), section 2.2, places transfer within the analytical procedure lifecycle and discusses justified approaches to additional work. It does not prescribe one identical experiment package for every transfer. ICH Q2(R2), including 2025 corrections.

Define exactly what is being transferred

Identify the product or material, analytical procedure version, intended use, receiving location and relevant reporting requirements. An assay for one purpose should not silently become approval for another product, matrix or reportable range.

Describe the sending and receiving laboratories' responsibilities. Include who provides materials, who approves the protocol, who evaluates deviations and who decides whether the transfer outcome supports the intended use. Commercial milestones should reference these decisions rather than replace them.

The transfer owner should also identify dependencies on the broader project. A product launch may require several methods, but they can reach readiness at different times. The technology-transfer readiness guide explains how to expose those dependencies without reporting a misleading overall completion percentage.

Assess readiness before scheduling execution

Compare the receiving laboratory's actual operating setup with the procedure and proposed protocol. Review relevant instrument capability, software and calculations, materials, standards, consumables, environmental conditions where applicable, and personnel preparation.

Capture differences as assessed items. A different instrument model is neither automatically acceptable nor automatically disqualifying. The analytical and quality owners determine the consequence and any required evidence. The workflow should make that assessment visible before resources are booked.

Do not use this table as a substitute for scientific protocol design. It is a coordination aid that helps the project locate unresolved prerequisites.

Choose and approve the transfer approach

The analytical owners should justify the approach using the method's knowledge, intended use and relevant differences between laboratories. Define the experiments or other evidence required, applicable performance criteria, treatment of deviations and the reporting process before execution.

ICH Q14 provides lifecycle context for analytical procedure development and change. Regional implementation and the actual product situation still matter. ICH Q14.

Avoid building acceptance limits into software because they appear in a generic template. Store the approved protocol version and its criteria so the system applies the correct basis to each assessment. Changes to that basis should follow the authorised process with an explanation of affected work.

Worked example: a unit mismatch changes the comparison

Consider an illustrative transfer in which the sending laboratory reports a result as 2.0 mg/L and the receiving laboratory reports 2,000 micrograms/L. The values are equivalent on that unit basis, but a spreadsheet comparing the numbers alone suggests a thousandfold difference.

Before judging analytical performance, preserve both original values and units, verify the intended comparison basis, and apply any approved conversion transparently. The converted result should remain linked to the original record and the calculation used.

Now suppose the laboratories also used different preparation conventions. A unit conversion cannot resolve that difference. The transfer lead must assess the actual procedure followed against the approved protocol, including whether the resulting data can support the planned comparison.

The receiving laboratory records the discrepancy, the analytical owners investigate it, and the authorised reviewers determine the next step. Additional work, if needed, follows an approved rationale. The system should not delete the first dataset or repeatedly request new results until a dashboard turns green.

This example illustrates data interpretation and exception handling. It does not define a method-specific acceptance limit or demonstrate that the transfer has succeeded.

Keep sample and result identity connected

Record the identities and relevant history of the samples used by each laboratory. Where samples are shipped, connect dispatch, receipt, condition assessment and any restrictions to the execution record. Similar labels are insufficient if aliquots or preparation histories differ.

The contract laboratory sample-tracking guide explains the handover evidence. For the receiving laboratory's internal work, the LIMS sample workflow separates receipt, testing, review and reporting states.

Preserve the relationship between reported results and underlying records. Reviewers should be able to identify the method version, analyst, relevant instrument record, calculations and any corrected report. A transfer summary containing only selected final values can hide the reason the laboratories disagreed.

Manage exceptions without losing the original plan

Give each deviation or unresolved difference an identifier, owner, affected scope and decision. Link it to the protocol activity and results involved. This makes it possible to assess whether the issue affects one execution, a wider dataset or the receiving laboratory's overall readiness.

Keep planned and actual execution dates separate. A delayed material shipment may explain schedule movement but does not establish analytical acceptability. Likewise, closing a project scheduling task should not close an unresolved scientific issue.

When the protocol changes, assess work already completed and work still pending. Preserve the earlier version and the reason for the revision. The final assessment should make clear which evidence was evaluated against which approved basis.

Make acceptance specific enough to use

The transfer report should identify the scope assessed, evidence considered, relevant exceptions, conclusions and any remaining limitations. The authorised decision needs to tell operations what the receiving laboratory is ready to do, rather than offering a broad “method transferred” label.

Update connected systems only to the approved extent. For example, making a method selectable in LIMS should follow the relevant readiness decision and configuration controls. It should not automatically open unrelated products or locations because they share a method name.

Communicate unresolved restrictions to planning and quality owners. A conditional project milestone can be useful, but downstream teams must understand the condition before assigning routine work.

Test the workflow before the next transfer

Use a completed transfer to check whether the proposed digital record can reconstruct the approved plan, actual execution and acceptance rationale. Include a unit mismatch, a protocol revision and an unresolved prerequisite in the demonstration.

Measure time spent obtaining missing evidence, unresolved readiness items at planned execution and repeated clarification cycles. Keep these operating measures separate from the scientific criteria used to assess the method. Faster coordination is valuable when the quality of the acceptance decision remains intact.

Summary and next actions

Method transfer succeeds through a justified plan, prepared receiving laboratory and reviewable evidence. A connected workflow helps the scientific owners understand differences and reach a scope-specific acceptance decision.

• Define the method, product, receiving laboratory and intended use for one upcoming transfer.
• Reconcile equipment, materials, competence and data conventions before approving the execution plan.
• Test unit conversion, protocol change and deviation handling with preserved source evidence.
• Publish the authorised readiness scope to laboratory and planning systems, including any remaining restrictions.